Bedolla R - Search Results

1

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI. Malik SN, et al. Among authors: bedolla r. Clin Cancer Res. 2002 Apr;8(4):1168-71. Clin Cancer Res. 2002. PMID: 11948129

2

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM. Kreisberg JI, et al. Cancer Res. 2004 Aug 1;64(15):5232-6. doi: 10.1158/0008-5472.CAN-04-0272. Cancer Res. 2004. PMID: 15289328

3

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.

Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI. Ghosh PM, et al. Endocr Relat Cancer. 2005 Mar;12(1):119-34. doi: 10.1677/erc.1.00835. Endocr Relat Cancer. 2005. PMID: 15788644

4

Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.

Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. Bedolla RG, et al. Clin Cancer Res. 2009 Feb 1;15(3):788-96. doi: 10.1158/1078-0432.CCR-08-1402. Clin Cancer Res. 2009. PMID: 19188148 Free PMC article.

5

RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta.

Ghosh PM, Bedolla R, Mikhailova M, Kreisberg JI. Ghosh PM, et al. Among authors: bedolla r. Cancer Res. 2002 May 1;62(9):2630-6. Cancer Res. 2002. PMID: 11980660

6

Akt in prostate cancer: possible role in androgen-independence.

Ghosh PM, Malik S, Bedolla R, Kreisberg JI. Ghosh PM, et al. Among authors: bedolla r. Curr Drug Metab. 2003 Dec;4(6):487-96. doi: 10.2174/1389200033489226. Curr Drug Metab. 2003. PMID: 14683476 Review.

7

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation.

Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, Ghosh PM. Bedolla R, et al. Clin Cancer Res. 2007 Jul 1;13(13):3860-7. doi: 10.1158/1078-0432.CCR-07-0091. Clin Cancer Res. 2007. PMID: 17606718

8

Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.

Ganapathy M, Ghosh R, Jianping X, Zhang X, Bedolla R, Schoolfield J, Yeh IT, Troyer DA, Olumi AF, Kumar AP. Ganapathy M, et al. Among authors: bedolla r. Clin Cancer Res. 2009 Mar 1;15(5):1601-11. doi: 10.1158/1078-0432.CCR-08-1389. Epub 2009 Feb 17. Clin Cancer Res. 2009. PMID: 19223508 Free PMC article.

9

Immunohistochemical determination of EGFR-tyrosine kinase inhibition in clinical samples.

Malik SN, Bedolla RG, Hidalgo M, Brattain MG, Kreisberg JI. Malik SN, et al. Methods Mol Med. 2003;85:135-40. doi: 10.1385/1-59259-380-1:135. Methods Mol Med. 2003. PMID: 12710204 Review. No abstract available.

10

Role of protein kinase C in arginine vasopressin-stimulated ERK and p70S6 kinase phosphorylation.

Ghosh PM, Bedolla R, Thomas CA, Kreisberg JI. Ghosh PM, et al. Among authors: bedolla r. J Cell Biochem. 2004 Apr 15;91(6):1109-29. doi: 10.1002/jcb.10789. J Cell Biochem. 2004. PMID: 15048868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters